RT Journal Article
SR Electronic
T1 Presence and vitality of SARS-CoV-2 virus in wastewaters and rivers
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.01.20086009
DO 10.1101/2020.05.01.20086009
A1 Sara Giordana Rimoldi
A1 Fabrizio Stefani
A1 Anna Gigantiello
A1 Stefano Polesello
A1 Francesco Comandatore
A1 Davide Mileto
A1 Mafalda Maresca
A1 Concetta Longobardi
A1 Alessandro Mancon
A1 Francesca Romeri
A1 Cristina Pagani
A1 Lorenzo Moja
A1 Maria Rita Gismondo
A1 Franco Salerno
YR 2020
UL http://medrxiv.org/content/early/2020/05/05/2020.05.01.20086009.abstract
AB Wastewater-based epidemiology has been proposed to monitor the diffusion and trend of SARS-CoV-2 pandemic. In the present study, raw and treated samples from three wastewater treatment plants, and two river samples characterized the Milano Metropolitan Area, Italy, were surveyed for SARS-CoV-2 RNA positivity to real time PCR and infectiveness. Moreover, whole genome sequencing and phylogenetic analysis of isolated strains was performed.Raw wastewater samples resulted positive to PCR amplification, while treated water samples were always negative (four and two samples, respectively, sampled in two dates). Moreover, the rate of positivity in raw wastewater samples decreased after eight days, in congruence with the epidemiological trend estimated for the interested provinces. Virus infectiveness was always not significant, indicating the effectiveness of wastewater treatments, or the natural decay of viral vitality, which implied the absence of significant risk of infection from wastewaters. Samples from receiving rivers (two sites, sampled in the same dates as wastewaters) showed in some cases a positivity to PCR amplification, probably due to non-treated discharges, or the combined sewage overflows. Nevertheless, also for rivers vitality was negligible, indicating the absence of sanitary risks. Phylogenetic analysis of genome indicated that the isolated virus belongs to the most spread strain present in Europe and similar to another strain found in Lombardy.Competing Interest StatementAll authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: no support from any organisation for the submitted work; Stefano Polesello has received research funds from Water Alliance – Acque di Lombardia company, while other authors has no relationships or activities that could appear to have influenced the submitted work.Clinical TrialThe submitted work did not represent a clinical studyFunding StatementNo external funding was received for the specific purpose of this workAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data referred to this manuscript are available upon request to the authors